What is NeuroGrafix?
NeuroGrafix, headquartered in Santa Monica, California, is at the forefront of neurologic visualization technologies. The company provides specialized services including advanced biophysics and magnetic resonance contract research, alongside visualization research and development for neural tract data. Their offerings also encompass information technology and data transport services, designed to streamline and integrate medical service organization functions for clinical entities. NeuroGrafix primarily serves clients requiring sophisticated solutions for neural tract data analysis and technology transfers for clinical applications, underscoring its role in advancing medical diagnostics and research.
How much funding has NeuroGrafix raised?
NeuroGrafix has raised a total of $49K across 1 funding round:
Debt
$49K
Debt (2021): $49K with participation from PPP
Key Investors in NeuroGrafix
PPP
Public-Private Partnership
What's next for NeuroGrafix?
With the recent influx of substantial expansion capital, NeuroGrafix is poised for significant operational scaling and technological advancement. The company's strategic focus on neurologic visualization and related data services indicates potential for deeper integration into clinical workflows and research initiatives. Future developments may include enhanced product offerings, broader market penetration, and strategic partnerships to leverage their advanced biophysics and IT capabilities. The company's trajectory suggests a continued emphasis on innovation within the medical technology sector, aiming to solidify its position as a leader in neural data visualization.
See full NeuroGrafix company page
